These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36081317)

  • 21. Epidemiological Characterization and Genetic Variation of the SARS-CoV-2 Delta Variant in Palestine.
    Ereqat S; Alikhan NF; Al-Jawabreh A; Matthews M; Al-Jawabreh A; de Oliveira Martins L; Trotter AJ; Al-Kaila M; Page AJ; Pallen MJ; Nasereddin A
    Pathogens; 2024 Jun; 13(6):. PubMed ID: 38921818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid and Accurate Identification of SARS-CoV-2 Variants Using Real Time PCR Assays.
    Borillo GA; Kagan RM; Marlowe EM
    Front Cell Infect Microbiol; 2022; 12():894613. PubMed ID: 35619652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comprehensive profile of SARS-CoV-2 variants spreading during the COVID-19 pandemic: a genomic characterization study from Chhattisgarh State, India.
    Negi SS; Sharma K; Bhargava A; Singh P
    Arch Microbiol; 2024 Jan; 206(2):68. PubMed ID: 38238530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of whole-genome tiling array at Shanghai port, China: An alternative method for SARS-CoV-2 surveillance.
    Liu D; Wang Z; Mao M; Zhang Z; Ding X; Zheng H; Li S; Zhang Z; Tian Z
    J Med Virol; 2023 Nov; 95(11):e29222. PubMed ID: 37964661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profiling post-COVID-19 condition across different variants of SARS-CoV-2: a prospective longitudinal study in unvaccinated wild-type, unvaccinated alpha-variant, and vaccinated delta-variant populations.
    Canas LS; Molteni E; Deng J; Sudre CH; Murray B; Kerfoot E; Antonelli M; Rjoob K; Capdevila Pujol J; Polidori L; May A; Österdahl MF; Whiston R; Cheetham NJ; Bowyer V; Spector TD; Hammers A; Duncan EL; Ourselin S; Steves CJ; Modat M
    Lancet Digit Health; 2023 Jul; 5(7):e421-e434. PubMed ID: 37202336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive analysis of clinical indications and viral strain variants among patients infected with SARS-CoV-2 in Inner Mongolia, China.
    Wang B; Li X; Xiao W; Zhang J; Ding H
    Virus Genes; 2023 Jun; 59(3):391-398. PubMed ID: 36905534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spatial growth rate of emerging SARS-CoV-2 lineages in England, September 2020-December 2021.
    Smallman-Raynor MR; Cliff AD;
    Epidemiol Infect; 2022 Jul; 150():e145. PubMed ID: 35855577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulation of SARS-CoV-2 Variants among Children from November 2020 to January 2022 in Trieste (Italy).
    Dolci M; Signorini L; Cason C; Campisciano G; Kunderfranco P; Pariani E; Galli C; Petix V; Ferrante P; Delbue S; Comar M
    Microorganisms; 2022 Mar; 10(3):. PubMed ID: 35336187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early Emergence and Dispersal of Delta SARS-CoV-2 Lineage AY.99.2 in Brazil.
    Romano CM; de Oliveira CM; da Silva LS; Levi JE
    Front Med (Lausanne); 2022; 9():930380. PubMed ID: 35783651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of mRNA-1273, BNT162b2, and JNJ-78436735 COVID-19 Vaccines Among US Military Personnel Before and During the Predominance of the Delta Variant.
    Eick-Cost AA; Ying S; Wells N
    JAMA Netw Open; 2022 Apr; 5(4):e228071. PubMed ID: 35442453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of new SARS-CoV-2 variant Omicron (B.1.1.529) on vaccine efficacy, its correlation to Delta variants: A computational approach.
    Ranjan P; Neha ; Devi C; Devar KA; Das P
    Microb Pathog; 2022 Aug; 169():105619. PubMed ID: 35690234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole Genome Sequencing of SARS-CoV-2 in Cats and Dogs in South Korea in 2021.
    Shin YK; Kwon OK; Heo J; Nah J; Kang HE; Kang Y; Song IJ; Sung HK
    Vet Sci; 2022 Dec; 10(1):. PubMed ID: 36669008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection and Interspecies Comparison of SARS-CoV-2 Delta Variant (AY.3) in Feces from a Domestic Cat and Human Samples.
    Lenz OC; Marques AD; Kelly BJ; Rodino KG; Cole SD; Perera RAPM; Weiss SR; Bushman FD; Lennon EM
    bioRxiv; 2022 Feb; ():. PubMed ID: 35132417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of Covid-19 Severity with SARS-CoV-2 NS8 Protein Mutations Depending on Virus Strain.
    Shkurnikov MY; Averinskaya DA; Komarov AG; Karbyshev IA; Speshilov GI; Shtinova IA; Doroshenko DA; Vechorko VI
    Dokl Biochem Biophys; 2022 Dec; 507(1):242-246. PubMed ID: 36786981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic surveillance of severe acute respiratory syndrome coronavirus 2 in Burundi, from May 2021 to January 2022.
    Nduwimana C; Nzoyikorera N; Ndihokubwayo A; Ihorimbere T; Nibogora C; Ndoreraho A; Hajayandi O; Bizimana JC; Diawara I; Niyonizigiye D; Nyandwi J
    BMC Genomics; 2023 Jun; 24(1):312. PubMed ID: 37301830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants.
    Blanquart F; Hozé N; Cowling BJ; Débarre F; Cauchemez S
    Elife; 2022 May; 11():. PubMed ID: 35587653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 AY.4.2 variant circulating in Italy: Genomic preliminary insight.
    Angeletti S; Giovanetti M; Fogolari M; Cella E; De Florio L; Lintas C; Veralli R; Francesconi M; Caccuri F; De Cesaris M; De Flora C; Ceccarelli G; Spoto S; Caruso A; Pascarella S; Riva E; Ciccozzi M
    J Med Virol; 2022 Apr; 94(4):1689-1692. PubMed ID: 34766651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic characterization unravelling the causative role of SARS-CoV-2 Delta variant of lineage B.1.617.2 in 2nd wave of COVID-19 pandemic in Chhattisgarh, India.
    Singh P; Sharma K; Singh P; Bhargava A; Negi SS; Sharma P; Bhise M; Tripathi MK; Jindal A; Nagarkar NM
    Microb Pathog; 2022 Mar; 164():105404. PubMed ID: 35065253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.